These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9204651)

  • 1. A randomized, controlled trial of intravenous clodronate in patients with metastatic bone disease and pain.
    Ernst DS; Brasher P; Hagen N; Paterson AH; MacDonald RN; Bruera E
    J Pain Symptom Manage; 1997 Jun; 13(6):319-26. PubMed ID: 9204651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effects of clodronate for the pain treatment of bone metastasis due to prostate cancer].
    Ozyuvaci E; Altan A; Demir C
    Agri; 2005 Jan; 17(1):49-53. PubMed ID: 15791501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Randomized trial of two administration schedule of bonephos (Clodronate) in patients with painful bone metastasis].
    Moiseenko VM; Blinov NN; Semiglazov VV; Konstantinova MM; Trishkina EA
    Vopr Onkol; 1998; 44(6):725-8. PubMed ID: 10087976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, crossover trial of intravenous clodronate in metastatic bone pain.
    Ernst DS; MacDonald RN; Paterson AH; Jensen J; Brasher P; Bruera E
    J Pain Symptom Manage; 1992 Jan; 7(1):4-11. PubMed ID: 1531673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind, placebo-controlled, randomized trial of oral sodium clodronate for metastatic prostate cancer (MRC PR05 Trial).
    Dearnaley DP; Sydes MR; Mason MD; Stott M; Powell CS; Robinson AC; Thompson PM; Moffat LE; Naylor SL; Parmar MK;
    J Natl Cancer Inst; 2003 Sep; 95(17):1300-11. PubMed ID: 12953084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous clodronate in the treatment of reflex sympathetic dystrophy syndrome. A randomized, double blind, placebo controlled study.
    Varenna M; Zucchi F; Ghiringhelli D; Binelli L; Bevilacqua M; Bettica P; Sinigaglia L
    J Rheumatol; 2000 Jun; 27(6):1477-83. PubMed ID: 10852274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Double-blinded controlled study comparing clodronate versus placebo in patients with breast cancer bone metastases].
    Tubiana-Hulin M; Beuzeboc P; Mauriac L; Barbet N; Frenay M; Monnier A; Pion JM; Switsers O; Misset JL; Assadourian S; Bessa E
    Bull Cancer; 2001 Jul; 88(7):701-7. PubMed ID: 11495824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind, placebo-controlled, dose-response trial of oral clodronate in patients with bone metastases.
    O'Rourke N; McCloskey E; Houghton F; Huss H; Kanis JA
    J Clin Oncol; 1995 Apr; 13(4):929-34. PubMed ID: 7707121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disodium clodronate in the treatment of pain due to bone metastases.
    Luzzani M; Vidili MG; Rissotto R; Nobile MT; Beghè F; Rosso R; Gottlieb A
    Int J Clin Pharmacol Res; 1990; 10(4):243-6. PubMed ID: 2150406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of oral clodronate on metastatic bone pain: a double-blind, placebo-controlled study.
    Robertson AG; Reed NS; Ralston SH
    J Clin Oncol; 1995 Sep; 13(9):2427-30. PubMed ID: 7666103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant i.v. and oral clodronate in the relief of bone pain--a double-blind placebo-controlled study in patients with prostate cancer.
    Kylmälä T; Taube T; Tammela TL; Risteli L; Risteli J; Elomaa I
    Br J Cancer; 1997; 76(7):939-42. PubMed ID: 9328156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of intravenous pamidronate and oral clodronate on symptoms and bone resorption in patients with metastatic bone disease.
    Jagdev SP; Purohit P; Heatley S; Herling C; Coleman RE
    Ann Oncol; 2001 Oct; 12(10):1433-8. PubMed ID: 11762816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clodronate therapy of metastatic bone disease in patients with prostatic carcinoma.
    Adami S; Mian M
    Recent Results Cancer Res; 1989; 116():67-72. PubMed ID: 2527401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The analgesic efficacy of clodronate compared with placebo in patients with painful bone metastases from prostatic cancer.
    Strang P; Nilsson S; Brändstedt S; Sehlin J; Borghede G; Varenhorst E; Bandman U; Borck L; Englund G; Selin L
    Anticancer Res; 1997; 17(6D):4717-21. PubMed ID: 9494595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of two different doses of oral clodronate on pain in patients with bone metastases.
    Arican A; Içli F; Akbulut H; Cakir M; Sencan O; Samur M; Açikgöz N; Demirkazik A
    Med Oncol; 1999 Sep; 16(3):204-10. PubMed ID: 10523801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pain relief and quality-of-life assessment following intravenous and oral clodronate in hormone-escaped metastatic prostate cancer.
    Cresswell SM; English PJ; Hall RR; Roberts JT; Marsh MM
    Br J Urol; 1995 Sep; 76(3):360-5. PubMed ID: 7551847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disodium clodronate in the treatment of diffuse sclerosing osteomyelitis (DSO) of the mandible.
    Montonen M; Kalso E; Pylkkären L; Lindströrm BM; Lindqvist C
    Int J Oral Maxillofac Surg; 2001 Aug; 30(4):313-7. PubMed ID: 11518354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trial.
    Serafini AN; Houston SJ; Resche I; Quick DP; Grund FM; Ell PJ; Bertrand A; Ahmann FR; Orihuela E; Reid RH; Lerski RA; Collier BD; McKillop JH; Purnell GL; Pecking AP; Thomas FD; Harrison KA
    J Clin Oncol; 1998 Apr; 16(4):1574-81. PubMed ID: 9552068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double blind randomized study of oral clodronate in the treatment of bone metastases from tumors poorly responsive to chemotherapy.
    Piga A; Bracci R; Ferretti B; Sandri P; Nortilli R; Acito L; Pancotti A; Di Furia L; Carle F; Cellerino R
    J Exp Clin Cancer Res; 1998 Jun; 17(2):213-7. PubMed ID: 9700583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of bisphosphonate for the palliative treatment of painful bone metastasis due to hormone refractory prostate cancer.
    Heidenreich A; Hofmann R; Engelmann UH
    J Urol; 2001 Jan; 165(1):136-40. PubMed ID: 11125382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.